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Structure of the epididymal retinoic
acid binding protein at 2.1 resolution
Marcia E Newcomer
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA

Background: Androgen dependent proteins in the
lumen of the epididymis are required for sperm maturation. One of these is a retinoic acid binding protein,
E-RABP, which binds both all trans and 9-cis retinoic
acid. The other retinoid-binding proteins whose structures are known do not bind 9-cis retinoids.
Results: We describe the X-ray structure determination of E-RABP with and without bound ligand. The
ligand binds deep in the [3-barrel of the protein, the
[3-ionone ring innermost. The binding site, like the lig-

and, is amphipathic and the deepest part of the cavity
is formed by a ring of aromatic amino acids. The iso
prene tail of all-trans retinoic acid is bound in a folded
conformation which resembles that of the 9-cis isomer.
Conclusion: E-RABP achieves high-affinity binding of
both all-trans and 9-cis isomers of retinoic acid by forcing the all trans form to bind in a folded conformation.
The RAR family of nuclear receptors for retinoic acid
also binds both isomers, and their binding sites may
therefore be similar.

Structure 15 September 1993, 1:7-18
Key words: 9-cis retinoic acid, lipocalin, vitamin A
Introduction

After sperm are produced in the testes they traverse the
epididymis and it is here, in the presence of a group
of androgen-regulated proteins, that they acquire the
ability to fertilize the egg [1-3]. One of the androgendependent proteins secreted by the epididymis is a
retinoic acid binding protein (E-RABP) [4,5] which
binds both all-trans and 9-cis retinoic acid [6], but not
retinol or retinal [4]. Both the 9-cis and all-trans isomers of retinoic acid have been found in the epididymis
[7]. An essential role for retinol in spermatogenesis
has long been recognized. However, high levels of the
cellular retinoid-binding proteins in epididymal tissue
[8-10] suggest a role for retinoids in sperm matura
tion as well. Cellular retinol-binding protein (CRBP)
is abundant in the proximal epididymis and cellular
retinoic acid binding protein (CRABP) is localized to
the distal epididymis [8,10]. The retinoic acid binding
protein we describe here is distinct from CRABP and
is found in the lumen of the epididymis [4,11,12].
Retinoic acid is well known as a morphogen and a
regulator of gene expression as either the 9-c~ [13-15]
or the all-transisomer [16,17]. Two families of retinoic
acid nuclear receptors have been identified. The family
designated RAIl binds both 9-cis and all-trans retinoic
acid with approximately equal atfinities, whereas the
RXR family binds only the 9-cis isomer and at a lower
al~nity than RAR binds either isomer [18]. High levels
of mRNA transcripts for the a and 13 isoforms of RAR
have been observed in epididymis [19]. This finding
f~.arther supports the possibility that retinoic acid may
be important in sperm maturation.
Retinoic acid is only one of several biologically active
forms of vitamin A. Physiological amounts of the vitamin, whether utilized as retinol, retinal or retinoic

acid, are transported as all-trans retinol to the target tissue by the serum retinol-binding protein (RBP)
[20], the structure of which has been previously described [21,22]. E-RABP and RBP share nominal sequence homology (less than 20 % sequence identity)
and overlapping ligand specificity (RBP can also bind
all-trans retinoic acid in vitro, with an affinity comparable to that for all-trans retinol). It has been predicted that the two proteins have considerable structural homology. We report here the structural determination of the retinoic acid binding-protein from rat
epididymis at 2.1~ resolution. The structural homology with the serum retinol-binding protein is substan
tial, but limited to the overall fold of the protein. The
retinoid binding sites occupy significantly different positions in the structural framework of the proteins, and
the bound ligands themselves adopt different conformations in the two proteins.
The X-ray structures of cellular retinol-binding proteins
CRBP and CRBP(II) have been described [23,24]. In
these proteins, which do not bind 9-cis retinol, the all
trans retinol is found to bind with the isoprene tail
fully extended, just as it is found in the binding site
of RBP. However, the retinol in CRBP is bound in the
opposite orientation relative to its position in RBP
the 13-ionone ring of retinol is b o u n d innermost in RBP
but in CRBP, retinol is bound with the hydroxyl group
buried deep in the binding site. E-RABP also binds
retinoic acid with the 13-ionone ring innermost. Like
the retinoic acid receptor RAIl, E-RABP binds 9-ci2 and
all- trans retinoic acid with equal affinity. In E-RABP the
isoprene tail of the ligand is 'folded' so that all-trans
retinoic acid adopts a conformation which resembles
9-cis retinoic acid. This observation probably accounts
for the ability of E-RABP to bind both isomers equally.
This report describes the structure of E-RABP both
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with and without its ligand (the holo- and apo-protein,
respectively) and the structural features that permit the
protein binding site to recognize both all-trans and
9-cis retinoic acid.

Results and discussion

of strands d e f g h a i. Helix A packs on top of strand b
in an antiparallel orientation. The direction of the chain
then reverses again so that strand i runs antiparallel
to strand a. The final carboxy-terminal segment wraps
round on to the 'top' sheet and forms an additional
<zhelix which packs on to strand b. In the first turn of
the terminal <z-helix Cys154 forms a disulfide bond with
Cys60 at the amino end of strand d

The overall structure of E-RABP

The retinoic acid binding protein is a globular protein
of the approximate dimensions 40 x 40 x 35 g,. In the
center of the protein is a very large and deep binding
pocket more than 15 ~ across at the entrance and 20 g,
deep. The basic structural framework of the molecule
is an eight-stranded up-and-down [£sheet core which
twists into a barrel. One end of the barrel is closed by
amino acid side chains in the barrel interior and amino
acid side chains from the amino terminus, which wraps
across the back end of the barrel. The front end of the
barrel is open and provides the entrance to the binding
site. A portion of the 2F o -Fc map and the correspond
ing volume in the multiple isomorphous replacement
(MIR) map are shown in Fig. 1.
About 60 % of the amino acids in E RABP are found in
<z-helical or I~-strand secondary structure, and roughly
threequarters of the secondary structure is [£sheet
(Fig. 2a,b). There are a total of nine [£strands, designated a to i, in the linear sequence and two <z-helices, A
and B, in addition to two <z-helical turns. In the lnear
sequence the relationship of the secondary structural
elements is as follows: a b c d e f g h A i B. The first <zhelical turn precedes strand a and the second is found
between helix a and [~-strand i. Each [£strand, a to h,
forms hydrogen bonds with the neighboring strand in
the linear sequence. This eight-stranded 13-sheet core is
twisted such that strand h may form hydrogen bonds
with strand a. Strand i also forms l-sheet contacts with
strand a. This results in a barrel consisting of two layers
of orthogonally stacked antiparallel t-sheets. Strands a
and d b e n d to form part of both the 'top' and 'bottom'
t-sheets, where the 'top' sheet is that composed of
strands a b c d a n d the 'bottom' sheet is that composed
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Most of the reverse turns which connect the neighboring [£strands in the antiparallel sheet are fairly short.
One notable exception is the connection between [3strands a and b, which is located at the binding site entrance in the tertiary structure. This segment of the protein is an irregular stretch of coil 15 amino acids long.
The E-RABP molecule itself has a pseudo two-fold symmetry axis perpendicular to the length of the barrel.
Rotation about this axis, illustrated in Fig. 3, causes not
only the two [£sheets which form the two sides of the
barrel to become superimposed, but also the <z-helices.
These pack onto the [3-sheets in approximately equivalent orientations and are also related by this pseudo
two-fold axis. In the superimposed molecules, the [3strands run in opposite directions, but the helices are
parallel. This intramolecular pseudo-syl'm-netry led to
some complications in the interpretation of the early
electron density maps. The asymmetric unit of the crystal contains two protein molecules which are designated molecule A and molecule B. In the original electron density map, the region of the map which corresponded to molecule B was especially poor. -Early
attempts to define the non-crystallographic symmetry
operation relating the two molecules used density correlation programs in which the electron density for the
volume of the map which corresponded to molecule
A was rotated and translated with respect to the volume corresponding to molecule B, to find the relationship which gave the maximum correlation value for
the electron densities. The best solution actually corresponded to orienting molecule A onto a molecule B
rotated about the pseudo two-fold axis. The peak in

Fig. 1. (a) A portion of the model and
of the apo-2F o Fc electron density map
contoured at 1.0 standard deviation.
(b) The same region of the original (unaveraged) 2.6A.MIR map, which is especially poor in this area, contoured at
1.0 standard deviation with the refined
model built in.
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Fig. 2. (a) A C0~ trace of the retinoic
acid binding protein. The regions of the
backbone which adopt a-helical or [3strand structure are in yellow. The secondary structure elements are labelled
according to the text. In this view the
[3-sheet formed by strands efg/'liis in the
foreground, the closed end of the barrel is on the left and the binding site entrance is on the right. (b) A stereo backbone trace for the same orientation as
in (a). (c) A stereo drawing of a space-filling model of E-RABP, rotated 90° about
the vertical axis relative to the view in (a)
and (b), looking into the binding site. All
backbone atoms are green. Side-chainatoms are as follows: C green, N blue,
O red, S yellow.
the sell:rotation f u n c t i o n w h i c h c o r r e s p o n d e d to the
m i s - o r i e n t a t i o n was only slightly l o w e r t h a n the interm o l e c u l a r true two-fold peak, which, b e c a u s e only part
of the m o l e c u l e c o n f o r m s to the non-crystallographic
symmetry, was itself lower t h a n m i g h t have b e e n exp e c t e d for a perfect i n t e r m o l e c u l a r two-fold axis.

Internal two-fold structural similarity in p r o t e i n s has
b e e n o b s e r v e d b e f o r e in multi d o m a i n proteins. For
example, the serine proteases are c o m p o s e d o f two l]
barrels related b y a p s e u d o two-fold axis. T h e p s e u d o
two-fold axis w o u l d b e c o n s i s t e n t with an inverted,
rather than a tandem, repeat in the a m i n o acid se
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Fig. 3. The superposition of E-RABP with
an image of itself rotated about the intramolecular pseudo two-fold symmetry
axis.

quence, should such a thing be possible (see [25]).
The internal structural homology occurs in a single
domain in E-RABP but is similarly consistent with an
'inversion' of that part of the sequence which codes
for the first half of the 13barrel.
Flexible regions of the molecule
As described above, there are two molecules of E-RABP
in the asymmetric unit. A substantial fraction of the
molecule does not conform to the non-crystallographic
symmetry relationship which relates molecules A and B.
This is because the flexible regions of E-RABP are not
sufficiently constrained or they adopt distinct conformations in the two molecules in the asymmetric unit,
(The Ca-backbones of the two molecules are superimposed in Fig. 4.) The longest loop in the protein is the
segment which connects 13-strand a with 13-strand b. For
much of this stretch, for either molecule A or molecule
B, the electron density is poor, suggesting that this region is a flexible loop. Other flexible loop/turn regions
at the open end of the barrel occur between 13-strands
c and d, e and f, and g and b. These regions adopt
different conformations in the two crystallographically
independent molecules, and the corresponding electron densities in the map are less well defined. There
are also two loops at the closed end of the barrel where
the two crystallographically independent molecules differ slightly. These two turns connect strands b and c
and strands d and e. The structural divergence in these
two areas appears to be a result of the crystal packing. A plot of the correlation of the calculated model
electron density (for main-chain and side-chain atoms)
with the electron density of the 2Fo-F c map is shown
in Fig. 5. The positions of the elements of secondary
structure are marked on the figure. It is apparent that
the correlation between the model and experimentally
observed electron density in the regions of the 13-stands
and a-helices is quite good, but that the electron density for the turns is not of the same quality. This structural heterogeneity makes it difficult to compare the
structures of these same Mops in the apo-protein with
those structures they adopt in the holo-protein. The
conformations differ not only between the apo- and
hob-forms of the protein, but also between the two
copies of the holo- and apo-molecules.

150

0

Fig. 4. The superposition of molecule A (thinner line) and
molecule B (thicker line). The orientation is the same as Fig. 2a.

We have chosen, therefore, to compare holo-molecule
B with apo-molecule B. Because the crystals are isomorphous, differences in the loop positions between
holo-B and apo-B cannot be due to differences in
the crystal packing environment. In addition, molecule
A is not as well substituted in the holo-crystal, as
• judged from the lower peak height in the MIR difference Fourier and the less well defined electron densit,/for retinoic acid in the 2Fo-Fc map. The reason
for the decreased substitution of ligand in the binding
site of molecule A can be explained by the fact that
Arg80, which interacts with the ligand carboxylate in
holo-molecule B, reaches out towards the protein surface in molecule A (in both the apo- and hob-crystal
structures) to form an intermolecular salt link which
stabilizes the crystal packing. The formation of this intermolecular salt link is possible because the side chain
of Leu81 in this same loop in molecule A is packed
into a hydrophobic pocket (formed by the exposed
side chain of Ile8) at the closed end of the 13-barrel of
molecule B. In the apo-structure of molecule B, Arg80
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is pointing into the barrel of molecule B to fOrTh an
intramolecular salt link with Glu63.
Real Space
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chain stretches out towards the binding site entrance
so that the positively charged amino group is at the entrance end of the binding site, near where the retinoic
acid carboxylate is located in the holo-structure. Additional positive charges are provided by Arg80 and
Lys85. Glu17 extends from the sheet opposite that containing Arg80 and Lys85. In the 2Fo-F c map of the
apo-structure there is a long stretch of electron density which starts at the the side chain amino group
of Lys115 and penetrates into the binding cavity. The
crystals were grown in the presence Of glycerol and it
is perhaps glycerol, and not water, in the apo-protein
binding cavity. The electron density nicely accommodates two molecules of glycerol end-to-end, with the
first able to form a hydrogen bond with Lys115.

Residue N u m b e r

Fig. 5. A plot of the correlation of the model electron density with
the electron density in the 2Fo-Fc map v e r s u s residue number.
Both main-chain and side-chain atoms were included in the calculation (O version 5.7). The dotted line is for molecule A and the
solid line for molecule B. The positions of the secondary structural
elements are indicated.

The conformational changes which occur upon ligand
binding include a rearrangement of side chains within
the binding site and some differences in the conformation of the loops at the entrance to the binding site. The
flexible Mops at the site entrance appear to move in
the holo-protein relative to the apo-protein. However,
it is difficult to quantitate the extent of the structural
changes since, as discussed above, the electron density
in these regions, although consistent with the models,
is less well defined.
The ligand-binding site
There is a large amphipathic cavity inside the [3-barrel
which forms the binding site and binding site entrance (Fig. 2c). The deepest part of the cavity is lined
with hydrophobic amino acids. Charged amino acids
are found in the cavity proximal to the binding site
entrance. The entrance itself, formed by the inside
faces of the two [3-sheets, has both hydrophobic and
charged amino acids. The side chains which form the
binding cavity are Phe6, Phe11, Trp15, Glu17, Met39,
Va141, Leu48, Leu50, Thr52, Tyr54, Va165, Phe76, Va178,
Arg80, Lys85, Va187, Va189, Ala98, Ilel00, Ile102, Thr113,
Lys115 and Tyr117. The presence of retinoic acid in the
binding cavity limits the accessible surface area of all
but Glu17 relative to the same surface in the holo-protein in the absence of ligand.

The aromatic amino acids Phe6, Phe11, Trp15, Phe76
and Tyr117 are deepest in the binding cavity and form
a semicircle which surrounds the [3-ionone ring of
the retinoic acid in the holo-protein (Fig. 6). These
side chains make van der Waals' contact with the
ligand around the perimeter of the [3-ionone ring. At
the entrance to the binding cavity are Glu17, Glu63,
Arg80, Lys85 and Lys115. The deepest of these residues
is Lys115. The a-carbon of Lys115 is located in the
hydrophobic portion of the binding site, but its side

In Fig. 6 the complementarity of the fit between ligand
and binding site is apparent. What is also quite clear
from the drawing is the amphipathic nature of the binding site and the striking distribution of the aromatic
amino acids around the 6-ionone ring. The amino acids
along the length of the isoprene tail are hydrophobic. The side chain of Met39 adopts a different conformation in the apo-structure. The presence of the
ligand in the binding site protects 187A2 of the sur
face area of the protein from solvent. Only 26 A2 of the
bound retinoic acid (of a total of 660A 2 for the free
ligand) is solvent accessible. (Water molecules which
are specifically bound were not included in this calculation. Bound water molecules protect the carboxylate
from accessibility by bulk solvent.) This 821 A2 reduction in the surface accessible area of largely hydrophobic surfaces ( > 8 5 %) makes the binding of ligand a
favorable process, given the estimate of 24 cal of free
energy gained per A2 of hydrophobic surface buried
[26]. However, small movements in the binding site
side chains reduce the accessible surface area of the
binding pocket in the apo-protein to only 116A2.
Ligand conformation
Like the retinol in the binding site of RBP, the [3-ionone
ring of the retinoic acid is innermost. The isoprene
tail is not, however, in the extended conformation as
it is observed to be in retinol in the binding sites of
RBP, CRBP and CRBP(II). The shape of the electron
density is consistent with that predicted for the 9-cis
isomer. However, the crystals of the holo-protein were
prepared using all-trans retinoic acid. (These isomers
are compared in Fig. 7.) Although isomerization could
easily have occurred over the length of time necessary
for crystal growth, extraction of the crystals confirmed
the presence of all-trans and 9-cis retinoic acid, in an
approximately 2:1 ratio, as well as 13-cis retinoic acid
[6]. The 13~cis isomer has a greatly reduced affinity
for E-RABP [4,6] and is not likely to be in the binding site, but is an abundant product of the light-driven
isomerization. The electron density we see for ligand
corresponds to a mixture of 9-cis and albtrans retinoic
acid, the all-trans isomer having adopted a 'pseudocid conformation by rotation of 180 ° about the C8-C9
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(b)

-...a,/

single b o n d (i.e., an '8-cid conformation). It has b e e n
estimated that significant twists about the C8-C9 single
bond in 11-cis-retinal can occur within 2 kcal of the
ground state energy [27].

C16

C19

C17

C20

I

I

02

C2

c

O1

I

II
c4

3

c12

~
c18

c14
AII-trans mtinoicacid

'8-cis' retinoicacid

:"

."-.

9-cis retinoicacid
Fig. 7. Structural formulae of retinoic acid isomers.

Fig. 6. (a) Stereo view of the binding
cavity and binding site entrance of ERABPwith bound ligand (in cyan). Atom
coloring is as follows: C green, N blue,
O red, S yellow. The accessible surface
area of the binding cavity is contoured
(probe radius 1.6A). (b) A line drawing
(in stereo) of the same view showing all
the side chains which form the binding
cavity and retinoic acid (thin line).

Ligand specificity
E-RABP was first identified as a retinoic acid binding
activity in extracts of rat epididymis. It was apparent
from competition studies with retinoic acid analogs
that the protein was distinct from CRABP, which is
abundant in epididymal tissue, because of the ability
of E-RABP to discriminate at both the 13-ionone ring
and carboxylate 'tail' ends of the retinoids. Like CRABP,
E-RABP binds retinoic acid but not retinol or retinal.
However, E-RABP does not bind some of the ringmodified retinoids which bind to CRABP. Such compounds include analogs which, in place of the ~-ionone
ring, have a 4-methoxy-2,3,6-trimethylphenyl moeity, a
pyridyl ring, or a trimethyl-thienyl ring, for example [4].
This ability to discriminate at both ends of the retinoic
acid analog can be explained by the structure of the
ligand-occupied binding site. As was apparent from Fig.
6, the ]£ionone ring, which has a ring-tail dihedral angle of - 160 °, fits snugly into the deepest part of the
binding cavity and makes favorable van der Waals' contacts with the surrounding amino acids. Since there is
little, if any, 'slack' in this area, modifications to the ring
structure may not b e readily accommodated.
At the 'tail' end of the ligand-binding site, electrostatic
interactions determine the specificity. Fig. 8 shows the
amino acids found at this end of the binding cavity,
as well as the b o u n d retinoic acid, and two of the
water molecules located in the binding site entrance.
There are three positively charged amino acids (Arg80,
Lys85 and Lys115) and two negatively charged amino

Structure of epididymal retinoic acid binding protein Newcomer

acids (Glu17 and Glu63) which point into the ]3-barrel
and are positioned for favorable electrostatic interaction. They constitute a network of charges with the
bound retinoic acid. Three negative and three positive
charges form a web across the open end of the barrel. As mentioned above, one of the positively charged
amino acids (Arg80) is pulled away from the binding
site in molecule A as a result of the crystal packing,
and molecule A has a reduced substitution of ligand in
the holo-protein crystal. This observation implies that
the integrity of the charge network is critical for ligand
binding. The positive charges provided by Lys85 and
Lysll5 are not sufficient to stabilize the binding of ligand. In addition, neither retinol nor retinal will bind to
E-RABP. Mthough these compounds both have polar
end groups, the negatively charged carboxylate is important for charge neutralization. The 13-cis isomer of
retinoic acid would position the ligand carboxylate t o o
far away from Arg80 and Lys85 and too close to Glu17
for the charge network to form. In the apo*structure,
the charged pairs Glu17:Lys115 and Glu63:Arg80 are
maintained. However, the side chain of Lys85 is pulled
away from the binding site towards bulk solvent.

Fig. 8. The charge network at the carboxylate end of the retinoic
acid binding site. Three positively charged amino acids (Arg80,
Lys85 and Lys115)and two negatively charged amino acids (Glu17
and Glu63) with the retinoic acid carboxylate form a network
of three charge pairs at the entrance end of the amphipathic
binding site. Additional polar side chains and water molecules
which participate in the network are included. Distances (A) are
given. The coloring is as follows: C green, N blue, O red, S yellow.
However, the retinoic acid carbon atoms are yellow.

Comparison of E-RABP with RBP
The topology of retinoic acid binding protein described above has previously been reported for the
human serum retinol-binding protein [21,22] and
other members of the ot-2 microglobulin superfamily
(also referred to as 'lipocalins'). The sequence identity
is generally low between the various pairs of members
of the superfamily, and E-RABP and RBP are no more
related to each other than RBP is to insecticyanin, an insect camouflage protein which binds biliverdin IX (for
example, see [22]). Lipocalins are secretory transport
proteins for a variety of hydrophobic or labile ligands.
So far, only a single enzyme, prostaglandin D synthase,
has been reported to be a member of this family [28].
Although RBP and E-RABP are proteins that have the
same structural motif and overlapping ligand specificity,
there are major structural differences between them.
These differences are presumably necessary to allow
E-RABP to be specific for retinoic acid (versus retinol
or retinal) as well as to accommodate both the 9-cis
and the all-trans isomers of the ligand in the binding
site. Those amino acid side chains that are conserved
between RBP and E-RABP cluster to the closed end of
the RBP barrel. None of the amino acids whose surface accessibility is limited by the presence of retinol
in the binding cavity of RBP are conserved in E-RABP.
In RBP the retinol hydroxyl reaches to the surface of
the protein and the ]3-ionone ring is bound innermost,
about halfway into the barrel [21,22]. In E-RABP the
binding site is located about 8 A deeper into the barrel
(the ligand itself is about 15 A long) so that the binding
site penetrates more than two-thirds of the way into
the barrel. This large invagination which is observed
in E-RABP (Fig. 2b) serves as both a binding site and
a large binding site entrance, making the cavity in this
protein exceptionally deep. In RBP, side chains fill up
the closed end of the barrel so that the binding cavity
in the apo-form is shallower.
In Fig. 9a the structures of RBP and E-RABP are superimposed (O version 5.6, as described in Materials
and methods) so that the alignment of the ]3-barrels is
optimized. The alignment of the amino acid sequences
according to the structural overlay is given in Fig. 10.
This alignment is similar to that previously predicted
[22], where E-RABP was identified as an 'androgendependent secretory protein'. The structural homology
between the two proteins is mostly localized to the
closed end of the barrel. This is the area where," in
the tertiary structures, a cluster of amino acids conserved throughout the protein family is found. There is
substantial variation between the two structures at the
entrance end of the barrels, where the proteins differ
in the extent of the ]3-sheets and in the conformations
and lengths of the loop regions. The root mean square
(rms) difference in positions for 97 (of a possible 164)
ot-carbons is 1.37A.. Only the Cot's of the ]3-barrels were
included in the superposition since helix A in E-RABP
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is moved relative to helix A in RBP and there is no helix
B in RBP.
Fig. 9b shows the side chains of the amino acids conserved between RBP and E-RABP and their respective
ligands. Those side chains found in the context of the
'cluster', which includes the majority of these identical residues, adopt similar conformations in the two
proteins. A notable exception is Phe11 (RBP Phe20)
which, if it adopted the same orientation as the corresponding amino acid does in RBP, would occupy
the innermost portion of the binding cavity, where the
[3-ionone ring is bound. In RBP, Phe20 is found in a
circular cluster of five phenyl rings. (The cognate amino
acids in E-RABP for three of these phenylalanines are
Va141, Ala67 and Lys115.) In E-RABP, the side chain of
Phe11 is oriented to make favorable aromatic-aromatic
interactions with Phe6, Trp15, Phe20 and Tyr117 at
the deepest part of the binding site. As a result, Tyr94
is displaced relative to its position in the RBP cluster, although the side-chain and main-chain conformation is similar to the corresponding amino acid in
RBP (Tyr114). Both Phe11 and Tyr94 are highly conserved throughout the lipocalin superfamily. In both
E-RABP and RBP, important interactions at the closed
end of the [3-barrel are made by Arg119 (RBP Arg138)
which packs onto Trp15 (RBP Trp24) and forms a
main chain hydrogen bond with Thr96 (RBP Thr116).
The single disulfide bond in E-RABP (Cys60:Cys154)
corresponds to one of the three disulfides found in
RBP (Cys70:Cys160).

(a)

Presumably the binding site for a primarily hydrophobic ligand has relatively few constraints, since it simply requires a hydrophobic pocket complementary in
shape to the ligand. A binding site that involves the formation of multiple hydrogen bonds between the ligand
and the protein is likely to be more tightly constrained,
since minor changes in side-chain packing might signifi
icantly affect the geometry of the hydrogen bonds.
There are 22 amino acids that form the ligand binding
site in E-RABP, and five of them are conserved in RBP
(see Fig. 10). However, none of these five forms part of
the ligand binding site in RBP. This illustrates the danger of arguing that conserved residues in homologous
proteins might have homologous functions. These five
amino acids are in positions in RBP that are important for maintaining the integrity of the [3-barrel. If the
structure of RBP were not known, an obvious experiment would have been to mutagenize these five amino
acids, expecting to obliterate retinol binding. This experiment would have had the expected effect, but for
the wrong reason; although none of the ligand binding amino acids would have been changed, the overall
structure of the [3-barrel would have been destroyed.
Although there is good conservation of the relative positions of the amino acids which form the binding sites
of the two proteins (13 of the 22 E-RABP binding site
amino acids occupy structurally conserved positions in
RBP), none of the residues themselves are conserved.
In Fig. 10, the binding site amino acids are indicated
for both E-RABP and RBP.

~/~

Fig. 9. Stereo views of the superposition
of (a) the Cot traces and (b) the conserved amino acids in the E-RABP/RBP
pair of lipocalins. E-RABP and retinoic
acid are represented by the thicker line
and RBP and retinol by the thinner line.
The numbering is for E-RABP.

Structure of epididymal retinoic acid binding protein Newcomer

a
b
c
. . . . . . . . . . . . . . . . . . . . . . . . . . .

i05
*

*

20¢
*

30~-

405
* * *

50]* * * *

E -RABP

RBP

E RDCRVS S F

~

K

E

~

~

K

D P~c~LF L Q . . . . . D N I V A E F S V D E T G Q M S ~ A K G R V

d
e
f
g
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

60~

70,~
*

RBP

* *

*

RLLNN~V~C~DMVGu~H~TE

*

805
*

D~F~MKYWGVAS

*

*

905
*

i00,~
* * * *

*

F LQR~N DDHW IVD~D~D~VQ

YSC ~

h
A
i
B
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ii0~
*

RBP

120~
* . .

N LDGTCADS YS FV~R~PNG

1305

140~

1505

160~

*

LPPEAQK IVRQRQEE LCLARQYRLIV~NGY~DGRS

In the crystal structure of the lipocalin odorant-binding
protein, a protein of the nasal mucosa thought to be
involved in odor sensation, the barrel interior is completely filled with side chains and the odorant binding
site is at the dimer interface [29]. It is apparent that
despite the overall structural homology between the
members of this protein family, the proteins vary in
the mechanism by which they recognize their respective ligands, even when the ligands themselves are also
structurally homologous. In RBP, because the ligand
hydroxyl is at the surface of the protein, there is no discrimination at the hydroxyl end. E-RABP is one of the
most specific retinoid-binding proteins yet described
[4,6] as it discriminates at both the ring and tail ends
of the retinoid molecule. The structures of two cellular retinoid-binding proteins have recently been determined. These proteins, CRBP [23] and CRBP(II) [24]
also have their retinoid-binding sites sandwiched between two layers of orthogonally stacked 13-sheet. CRBP
and CRBP(II), however, belong to a distinct structural
class, as they are composed of 10-stranded [3-barrels
and the barrel entrance is blocked by a pair of w
helices. These proteins, like E-RABP, discriminate at
the hydroxyl/carboxyl end of the retinoid. However,
in these proteins the retinol is inserted into the barrel
hydroxyl end first rather than [3-ionone ring end first, as
it is in RBP and E-RABP. Another striking contrast is the
inclusion of multiple water molecules in the binding
sites of CRBP and CRBP(II). In CRBP the binding cavity
includes eight water molecules as well as the retinol
and as a consequence the contours of the protein do
not conform as closely to the shape of the ligand as
they do in E-RABP. In both CRBP and CRBP(II) the
bound water molecules form an integral part of the
binding site and contribute to the formation of a binding cavity.

ERNLLRP

Fig. 10. A structure based s e q u e n c e
alignment of the amino acid sequences
of E-RABP (top line) and RBP (bottom
line). The numbering is for E-RABP. Conserved amino acids are in bold and enclosed in boxes. The secondary structural elements of E-RABP are indicated
and labelled as in Fig. 2a. 13-strand
amino acids which point into the ERABP barrel are marked (*). Amino acids
which form the ligand binding sites are
indicated with ( A ).

Biological implications
We have described the structure of a retinoic acid
binding protein (E-RABP) w h i c h is found in the
lumen of rat epididymis, the site of s p e r m maturation. It has long b e e n recognized that there is
a nutritional r e q u i r e m e n t for vitamin A (retino!)
for the maintenance of epithelial tissue, and consequently, normal epididymal function. However,
the p r e s e n c e of androgen-regulated E-RABP in the
lumen of the epididymis suggests that retinoids
may also be important in s p e r m maturation. ERABP is a m e m b e r of a family of s e c r e t o r y transp o r t proteins for h y d r o p h o b i c or labile ligands,
the lipocalin superfamlly, and may serve to shuttle
retinoic acid b e t w e e n the epididymal tissue and
s p e r m in transit.
The overall fold of E-RABP was p r e d i c t e d from its
s e q u e n c e h o m o l o g y w i t h h u m a n serum retinolbinding protein (RBP), w i t h w h i c h it also shares
functional homology. However, the ligand binding sites of the t w o proteins are very different. E-RABP binds the amphipathic retinoic acid
molecule d e e p within the ~-barrel f r a m e w o r k of
the protein, with the ~-ionone ring innermost,
s u r r o u n d e d by a cluster of aromatic amino acids.
The exquisite specificity of E-RABP for retinoic
acid is d u e in part to the positioning of a charge
n e t w o r k at the polar e n d of the amphipathic binding site, and in part to t h e site's overall shape.
Unlike RBP, E-RABP can bind the 9-cis isomer
of retinoic acid as well as the all-trans isomer,
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a n d o u r s t r u c t u r e s h o w s t h a t t h i s is a c h i e v e d b y

binding the all-trans i s o m e r i n a f o l d e d c o n f o r m a t i o n that resmbles the 9-cis i s o m e r , i n s t e a d o f
i n a n e x t e n d e d c o n f o r m a t i o n . B o t h 9-cis a n d alltrans r e t i n o i c a c i d a r e f o u n d i n t h e e p i d i d y m i s ,
a n d b o t h i s o m e r s a r e also l i g a n d s f o r t h e n u c l e a r

retinoic acid receptor RAR. It is possible that,
like E-RABP, RAR binds all-trans retinoic acid in
a folded conformation. Thus the binding site of
E-RABP may serve as a starting point for the design
of synthetic retinoic acid analogs as therapeutic
agents.

Materials and methods

Protein purification and crystallization
The retinoic acid binding protein was purified from frozen rat
epididymis as previously described [5]. The protein is expressed
in two forms, designated B and C and differing by an additional three amino acids on the amino terminus of the latter, but indistinguishable with respect to ligand binding affinity
and specificity. Crystals were grown of the apo-B form under
conditions similar to those previously described [5]: 40 % sat
urated ammonium sulfate, 10mM Tris-HC1 (pH8.0), 10-12%
glycerol, 2.5 mM EDTA at room temperature. Holo-protein crystals were prepared from protein to which retinoic acid (in
DMSO) had been added from 31% saturated ammonium sulfate,
10n-flVl Tris-HC1 (pH8.0), 10-12% glycerol, 2.5raM EDTA. Although the two crystal forms appear quite different, both apoand holo protein crystals belong to space group P21 and are
reasonably isomorphous with respect to unit cell parameters:
apo- a=39.33 b=58.67 c=66.274 13= 109.35°; holo- a=39.80
b = 58.89 c = 66.654 13= 109.44°. As was indicated by the results
of the self-rotation function, there are two molecules per asymmetric unit related by a two-fold along the a axis of the unit cell.

X-ray data collection
X-ray data were collected at room temperature with a pair of
San Diego multiwire area detectors mounted on a Rigaku RU-200
rotating anode. The apo data were 99.8 % complete to 2.1 4 resolution (63562 reflections, 16724 unique, Rmeme= 5.48 %). The
average VcI for the highest resolution shell (2.26-2.104) was 4.8.
For the hologrotein the data were 94.8 % complete (53778 re
flections, 14116 unique, Rmerge= 6.88 %) to a resolution of 2.24
with I/cr for the highest resolution shell (2.37-2.204) of 2.7. A
single crystal was used for each data set.

Structure solution and refinement
The structure of the apo-protein was solved by the method of
isomorphous replacement (MIR, Table 1). Data from four heavy
atom derivatives were used to calculate the initial MIR map to
2.64 resolution. This map was of poor quality (figure of merit
0.567) but from visual inspection it was possible to roughly
locate a center of non-crystaflographic symmetry which was in
agreement with the heavy atom positions of those heavy atom
derivatives with multiple binding sites and the locations of the
two retinoic acid molecules determined by a difference Fourier
calculated with the MIR phases. Some regions of 13strands were
visible, especially in one of the molecules of the asymmetric unit
(molecule A). An earlier attempt to solve the structure of the
protein by the method of molecular replacement with a model
based on the structure of retinol-binding protein as a starting
model had failed due to the fact that a solution to the trans-

lation function could not be found. However, it was apparent
from inspection of the MIR map that the crude model had been
properly oriented in the rotation function, as least for the one of
the molecules in the asymmetric unit which had clearer electron
density (molecule A).

Table 1. Heavy atom data.
Derivative

Mersal EMTS MMC

% Completeness
Resolution
Rmerge (%)
Rculns
Average isomorphous
differences in intensities (%)
Binding site(s)
Phasing power

84
3.0/~,
5.28
0.643
17.7
4
1.67

*Friedel pairs not merged. Rrnerge= E l l

94*
94*
2.6,~ 2.6/~,
6.89* 6,70*
0.618 0.615
19.8
10
1
1.53

2
1.39

K2PtCI 4

83
3.0/~,
5.1
0.624
13.2
1
1.73

- {I}i

where I= intensity measurement for a given reflection and {I} is
the mean intensity for multiple measurements of this reflection.
I FpH-FpI - IFH(calc) l
Rcullis= ~
~ i Fell - Fp[
Fp, FpH = structure factor amplitudes for protein and proteinheavy atom; FHlcalc ) = calculated heavy atom structure factor
amplitude, summed over centric data. Phasing power = < F H > / E
rms heavy-atom structure factor amplitudes/residual lack of
closure error. Mersal, mersalyl acid; EMTS, ethyl mercuric
thiosalicylic acid; MMC, methyl mercuric chloride.

Given the (at best) marginal quality of the MIR map it would have
been easy to over interpret the electron density to give a structure resembling that of RBP. In order to avoid the introduction
of errors into the structure, only those regions of density which
clearly corresponded to 13-strandswere interpreted. A 2.8~ resolution map was subsequently improved by phase combination
with partial structure phases and averaging with respect to the
non-crystallographic symmetry (NCS). The first improved map,
calculated from MIR phases which were phase combined with
partial structure phases for 82 alanines per monomer and then
averaged with respect to the non-crystallographic symmetry, had
a figure of merit of 0.838. After seven cycles of map interpre
tation, partial structure phase calculation, phase combination
and averaging, 154 amino acids of a possible 164 were placed
for each monomer. The center of non-crystallographic symmetit and symmetry operator were re-refined each cycle. As more
structure was included in the calculation of the partial structure
phases, the number of cycles of map averaging was decreased.
Regions outside the volumes of the map delineated with molecular masks for the volumes of the maps to be averaged were at
no time solvent leveled. During this stage of map interpretation
all X-ray data to 2.64 were included.
The first 2Fo-Fc map was calculated to 2.1_~ resolution with
phases from the 2.64 resolution model. Averaging of this initial
2Fo-Fc map with respect to the non-crystallographic symmetry
greatly improved the map quality. All subsequent maps were
straight 2Fo Fc maps calculated with model phases. Until the
R-factor reached 25 % all X-ray data from 20 to 2.1-& resolution
were included in the map calculations. Subsequently, a 2or cutoff was applied. The structure was refined with the simulated
annealing protocol in X-PLOR version 2.1 [30] after each cycle
of map interpretation. In the early stages of refinement no non-
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crystallographic symmetry restraints were applied. All 164 amino
acids were placed for molecule B and 160 for molecule A.
Once the model reached an R-factor of 22 %, non-crystallographic restraints were applied to the main-chain atoms of a
portion of the molecule. It was clear during the refinement process that several of the loop regions adopted distinct conformations in the two molecules. In order to verify the structural
divergence in these areas, the loops were built to be equivalent
in both structures, either as in the conformation observed in
either of the two copies of the protein or in a conformation
consistent with an 'averaged' electron density. However, these
regions invariably diverged with further refinement. The noncrystallographic restraints were then only applied to 75 % of the
backbone atoms. After a round of slow-cooling with the noncrystallographic symmetry restraints applied, followed by refinement of the atomic B-factors, the structure was refined with the
positional refinement protocol with X-PLOR, with the weight for
the X-ray term put at 75 % of the calculated value and no NCS
restraints applied. In subsequent positional refinements no NCS
restraints were applied.
The holo-protein
The initial model for the holo protein was that of the apoprotein with those water molecules not in or near the binding site, and the retinoic acids molecules and side chains of
Met39 positioned according to a difference Fourier calculated
with MIR/partial structure phases (with no averaging). A difference Fourier with phases calculated from a rigid-body refined
apo-structure against the holo data in which molecules A and
B and the water molecules as a whole were each treated as a
group gave equivalent peaks. After multiple Wcles of rigid body
refinement for each monomer and each ligand, the structure was
refined by the simulated annealing protocol in X-PLOR with seve r n cycles of model rebuilding in the 2F o Fc maps. The model
of retinoic acid was the all-trans isomer from the X-ray coordinates [31] with a 180 ° rotation about the C8-C9 bond.
Model quality
The final R-factor for the apo-model is 19.6 % for data between
6.0 and 2.1 ~ resolution (F > 2e, 94 % of all possible data in the
resolution range) and 18.2 % for the holo-model with data be
tween 6.0 and 2.2A resolution (F > 2e, 87 % of all possible data
in the resolution range). The rms deviations in atomic positions
for the main-chain atoms in the portion of the structure which
conforms to the non-crystallographic symmetry is 0.41 ~_ (1.10~
for all main-chain atoms) for the apo- and 0.47Jr (1.15A for
all main-chain atoms) for the holo-structure. A summary of the
refinement statistics is given in Table 2.
The model has been examined with the program PROCHECK
version 2.1 [32]. Of the ten parameters evaluated, which include
an assessment of the quality of the Ramachandran plot and analysis of peptide bond geometry, bad contacts and hydrogen bond
energies, as well as parameters relevant to side chain geometry,
nine fall inside the bounds established by well refined structures
of equivalent resolution. The tenth parameter, the measure of Ccz
distortion, is on the better side of this region.
A plot of the correlation of the calculated and observed electron
density for side-chain and main-chain atoms (as calculated with
O version 5.7 [33]) versus residue number is given in Fig. 5.
The correlation is excellent in the regions of the molecule in
regular secondary structure, an indication that the sequence of
the polypeptide as placed is in agreement with the observed
electron density.
The PHASES package (W Furey, VA Medical Center and Univer
sity of Pittsburgh) was utilized for the location and refinement
of heavy atom positions, phase refinement, phase combination,

Table 2. Summarized model refinement statistics.

R-factor (%)
Cutoff
% Measured data included
Protein/ligand atoms
(non-hydrogen)
Water molecules
Resolution range
Main chain average B factor
(molecule A)
(molecule B)
Deviations from ideality
Bond lengths
Bond angles

Apo-structure

Holo-structure

19.6
F > 2a
94

18.2
F > 2~
92

2537
119
6.0-2.1 ,a,

2581
72
6.0-2.2/~

21.1 ,a2
22.7 ~,2

25.1 A 2
27.5/~, 2

0.018/~
3.73"

0.017/i
3.37"

R-factor : ~Ch II %[ = I Fc IIh
~hIFolh
Fo = observed structure factor amplitudes; Fc = structure factor
amplitudes calculated from model.

averaging and calculation of all maps prior to refinement. Map interpretation, model building, and the comparison of RBP and ERABP was done on a Silicon Graphics 4D70GT with the program
O version 5.6 [33]. Refinement of the structure was done with
the simulated annealing protocol in X-PLOR version 2.1 [30].
The atomic coordinates have been deposited with the Brookhaven protein data bank.
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